Ljudmila Stojanovich received her Ph.D. in Medicine, with the thesis “Neuropsychiatric manifestations in patients with Systemic Lupus Erythematosus” in 1999. She is the scientific director in the Bezhanijska Kosa, University Medical Center of Belgrade University, where she is currently a Full Research Professor. Dr. Stojanovich’s research focuses on Systemic Lupus Erythematosus, Antiphospholipid Syndrome, and Vaccination in patients with Autoimmune Rheumatic diseases. She is an author of three monographs and of about 250 articles on various aspects of Autoimmune Rheumatic disorders, published in international and domestic journals and in conference proceedings. She is in Editorial Boards (Editorial Boards LUPUS (LONDON). /Reviewer in the “CURRENT CONTENSTS” or “Science citation index”, like LUPUS REWIEWER DATABAS, Cellular and Molecular Neurobiology, The Journal of Vaccine

Systemic Lupus Erythematous, Antiphospholipid syndrome, Neuropsychiatric manifestations in patients with systemic Lupus Erythematous, Vaccination in patients with auto-immune inflammatory rheumatic diseases

Dr. Rajendra D. Badgaiyan, MD, completed his MD from Harvard Medical School and had postdoctoral training in neuroimaging and cognitive neuroscience. He is the Chairman of the Department of Psychiatry and Behavioral Sciences at Richmond University Medical Center, and Professor of Psychiatry at Icahn School of Medicine at Mount Sinai in New York. His research is funded by NIMH, NINDS, VA, and various foundations. Previously he served in the faculty of Harvard Medical School, SUNY Buffalo and University of Minnesota. He has published over 150 papers in peer-reviewed journals.

Dr Badgaiyan’s research is focused on the study of neural and neurochemical mechanisms that control human brain functions. He developed the single scan dynamic molecular imaging technique (SDMIT) to detect, map, and measure neurotransmitters released acutely in the human brain during task performance. This technique is now used in laboratories all over the world. Using this technique, he studies dopaminergic control of human cognition and behavior. He is also interested in learning the nature of dysregulated dopamine neurotransmission in psychiatric and neuropsychiatric conditions

Dr Schmidt is a member of the European Force on Age-related White Matter Changes. He is also a member of the Austrian Society of Neuroimaging, and the Austrian Society for Stroke Research, and the president of the Austrian Alzheimer Society, and of the Working Group Neuroepidemiology and Prevention of the Austrian Neurological Society. He is a member of the VITATOPS-Steering Committee: a worldwide project on homocysteine-lowering multivitamin therapy in patients with recent ischaemic attacks or stroke. Dr Schmidt is or has been a principle investigator in the CASCADE study on diabetes and cortical atrophy stratified by abscence and presence of hypertension, in the Honolulu-Asia Aging Study, and in the Austrian Stroke Prevention Study.

Dr Schmidt`s clinical and research interests focus on the managing and treatment of vascular dementia combined with cerebrovascular diseases, in the pathophysiology of vascular cognitive impairment and Alzheimer`s Disease, in white matter lesion progression in patients with small vessel diseases, and in the prevention of diabetes.

Dr. Pragatheswaran is currently working as a Medical Director at Madurai Medical Centre with comprehensive services of specialists in ENT, Ophthalmology, Neurology, Neuro surgery, Psychologist, Sociology counselling for the past 28 years (1988 to 2016). He is an honorary medical Director in Guru Cancer Institute and also a senior medical director at public health care foundation, he has taken his doctorate in Hospital Management at European Continental University. He has his special training in general medicine and completed his MBA in health care and Hospital Administration from South Californian University.

Senior administrative medical officer in a large super speciality hospital with more than 3200 beds in south India. With a blend of meticulous surveillance over quality of the services of the medical / Para medical/ non-medical/ technical personnel rendering unblemished services. Done more than 700 tonsillectomies/ hundreds of Smr, Septoplasties and assisted hundreds of head and neck and facio -maxillary surgeries.

Linu has completed her PhD from Manipal University. She has completed her MS in Counseling and Psychotherapy. Currently she is working as Professor in Manipal College of Nursing, Manipal University, India.

Bipolar Disorder, Psycho-education, Quality of life, Bio psychosocial aspects of breast cancer patients.

Professor WK Tang was appointed to professor in the Department of Psychiatry, the Chinese University of Hong Kong in 2011. His main research areas are Addictions and Neuropsychiatry in Stroke. Professor Tang has published over 100 papers in renowned journals, and has also contributed to the peer review of 40 journals. He has secured over 20 major competitive research grants. He has served the editorial boards of five scientific journals. He was also a recipient of the Young Researcher Award in 2007, awarded by the Chinese University of Hong Kong.

Psychiatry, Addictions and Neuropsychiatry , Stroke

Natural from Portugal, did her nursing training in Lisbon where worked for 8 years in a central hospital in an acute medical ward with a stroke unit. During this time she did her Post graduation in Elderly/Geriatric and a Specialization and Master in Rehabilitation with training in Alcoitao Rehabilitation center. In 2014 decide to challenge herself and moved to Kingdom of Saudi Arabia where worked in a Stroke Unit in King Fahad Hospital – National Guard Health Affairs Hospital for one year and half. Here experienced to be a charge nurse and clinical resource nurse and worked with 52 different nationalities in a specific cultural context. In February’16 joined Amana Healthcare Hospital in UAE as a rehabilitation nurse. Helped the team to achieve the CARF accreditation and became Stroke Coordinator.

Neuro Rehabilitation, Stroke

Chairman & CEO at Alzheimers Disease International, London, United Kingdom Studied M.B.B.S at University of Mysore Past: st.marys high school,thalacode Lives in Trichur, Kerala, India

Alzheimers and related diseases

Graduated in Medicin from Universidade Federal de Santa Catarina (1988), medical residence in internal medicine and clinical neurology (1989-93); masters in internal medicine by Universidade Federal do Paraná (2003); PhD by Universidade de São Paulo (2008); Post- Doctoral by University of Edinburgh, UK (2011). Has experience in Neurology, Collective Health, focusing on Epidemiology, acting on the following subjects: stroke epidemiology, primary and secondary prevention of atherosclerosis, biobank and stroke units. Professor of Neurology and pos-graduation program at University of Joinville, Brazil. Coordinator of Joinville Stroke

Clinical Neurology, Internal medicine

Neuroscience Research NEUROHEALTH NEUROCIENCIAS Aplicadas (NEURONA) at Neurohealth Neurociencias Aplicadas, Senior management - Founder and researcher Neuroscientist at Fundacion Neurona and rotating internship - applied researcher at UNCIP Unidad de Neurocirugía Pediátrica

Neuroscience, Neurology

Neurologist and board certified Neurointensivist, currently pursuing further training in Endovascular Surgical Neuroradiology. My research expertise is in the pathophysiology of subarachnoid hemorrhage and especially in cerebral vasospasm as well as acute ischemic stroke. My goal is to synergize my clinical training and research skills; to gain in depth understanding of subarachnoid hemorrhage and ischemic stroke and to better treat various other devastating neurological diseases. I strive to improve patient outcomes by early identification of novel treatment targets and enable innovations in precision medicine.

Neuroradiology, Neurosurgery

Dr. Suhail Rasool has expertise in evaluation and passion in identifying therapeutic modalities for various Neurodegenerative diseases including Alzheimer’s disease. In the last 6 years Dr. Suhail has published more than 20 papers in peer reviewed and high impact factor journals. I have put forth significant contributions to my field. I have screened various conformation antibodies and I also have studied the effects of various antibodies and antigens for treatment of Alzheimer’s disease. I studied the various transgenic mouse mice models and Alzheimer’s disease human brains by utilizing various conformational antibodies and antigens

Alzheimer’s disease, Neurodegenerative diseases

Research Associate at CHU Sainte-Justine, CEO at Neurotechsr and Postdoctoral Researcher at Montreal Neurological Institute. Studied Sciences neurologiques at Université de Montréal

Neurosceince and Neurology

Professor WK Tang was appointed to professor in the Department of Psychiatry, the Chinese University of Hong Kong in 2011. His main research areas are Addictions and Neuropsychiatry in Stroke. Professor Tang has published over 100 papers in renowned journals, and has also contributed to the peer review of 40 journals. He has secured over 20 major competitive research grants. He has served the editorial boards of five scientific journals. He was also a recipient of the Young Researcher Award in 2007, awarded by the Chinese University of Hong Kong.

Psychiatry, Addictions and Neuropsychiatry , Stroke

Bruno Giometto, MD, is the director of Dept. of Neurology in Padova and was coordinator of the PNS Euronetwork. He has published more than 80 papers in peer-reviewed journals. He is Vice-President of the Italian Neurological Society.

NeuroOncology,Neurology

Nancy Ratner, PhD, is interested in understanding mechanisms of peripheral nerve tumor (neurofibroma) formation in neurofibromatosis type 1 (NF1), a common inherited disorder in which children are predisposed to cancer of the nervous system, to learning problems, bone disorders, and other cancers. She identified EGFR and MEK as potential therapeutic targets in NF1 peripheral nerve tumorigenesis, and has developed cell culture and mouse models of NF1 nerve tumorigenesis. Her laboratory has also used analysis of gene expression to identify critical genes in neurofibroma and their malignant derivatives, MPNST.Dr. Ratner received her bachelor's from Brown University, her doctorate from Indiana University, and was a postdoctoral fellow at Washington University in St. Louis. She was a member of the faculty at the University of Cincinnati from 1987 to 2004.

Molecular Biology, Cancer Biology and Neural Tumors.

Guido Cavaletti, MD, is a certified neurologist since 1990. He is the Head of the Experimental Neurology Unit at the University of Milano-Bicocca and has a long-lasting experience in the preclinical and clinical assessment of CIPN. He has published more than 200 full papers in peer-reviewed journals, he is is consulted by the FDA, NIH and EMA and has been serving as associate editor of the Journal of the Peripheral Nervous System and as editorial board member of Experimental neurology and Current medicinal Chemistry.

Neurology

Dr. Aizenberg is an Associate Professor of Neurosurgery at the University of Nebraska Medical Center. She is Board Certified by the American Board of Neurological Surgery. Dr. Aizenberg has completed fellowship training in Neurosurgical Oncology at The University of Texas M. D. Anderson Cancer Center and has a special interest in primary and metastatic tumors of the brain and spine.

NeuroOncology and Neurosurgery

Associate Professor of Neurosurgery at the University of Nebraska Medical Center. She is Board Certified by the American Board of Ammirati Mario is an expert in Neurological Surgery.He has completed fellowship training in Neurosurgical Oncology at The The Ohio State University and has a special interest in primary and metastatic tumors of the brain and spine.

Primary and metastatic tumors of the brain and spine.

Yusuf Al-Bustanji is an assistant professor at United Arab Emirates University. He is a licensed and certified speech language pathologist specializing in Neurogenic Communication Disorders from The Ohio State University. He has over 20 years of experience in providing clinical evidence-based therapy services to individuals diagnosed with communication and swallowing disorders in acute care and rehabilitation centers at hospital settings.

Dr. Qureshi is a Fellow in the Royal College of Physicians and Surgeons of Canada in the specialty of Neurology, a Member of the American Academy of Neurology, and a Member of the Canadian Society of Clinical Neurophysiologists. Graduate Of King Faisal University/ Dammam University Neurology Residency at university of Toronto 2003 Dr. Qureshi is active in many organizations. She is currently the Head of the Scientific Committee and Vice President of the Saudi Stroke Association, a Member of the executive board of the Saudi Neurology Society, a Member of the editorial board of the Saudi Medical Journal, and Ex-Head of the Islamic League for Sciences in the Eastern Province of Saudi Arabia. Member of Executive Board Of Saudi Epilepsy Society and Saudi chapter of epilepsy in past Member of faculty of 1000 at international league against epilepsy . Helped in organization and Program review of many SAGA and SSA scientific activities. Public awareness programs mainly in Eastern province almost every year .Promotion of stroke through multitudes of lectures at academic centers, community and along with teaching courses. Established stroke pathway. Established adopted orders for thrombolysis, acute stroke care and transfer of stroke patient with our institute

Neurosurgery, Acute Stroke therapies and thrombolysis

He is Associate Professor of Neurosurgery, Head, section of Neurological Surgery, Department of surgery, college of medicine, King Abdulaziz University, Jeddah. He is also member of the scientific committee of the Saudi Neurosurgery program for the Saudi Council for Health Specialties.He founded and established Neurosurgery department of surgery at KAU, Jeddah in 1998. Surgery for Brain Tumors, Epilepsy Surgery,Spine Surgery,Pediatric Neurosurgery,Vascular Neurosurgery.

Dr. Howard Prentice obtained his Ph.D. from the University of London, UK and after post-doctoral training in the USA held a faculty position at the University of Glasgow, UK from 1993-2000. He then joined Florida Atlantic University in Boca Raton where he is currently associate professor of Biomedical Sciences in the College of Medicine. From 2013-2014 he was visiting associate professor at Harvard Medical School, Boston. Dr. Prentice has more than 60 peer reviewed publications. He has been serving on study sections for the American Heart Association and the NIH and on editorial boards of several international scientific journals.

Dr. ZhiGang Xiong is Director of the Neurophysiology Program of the R. S. Dow Neurobiology Laboratories at the Legacy Clinical Research Center. Dr. Xiong is an inventor of our acute stroke therapy.Dr. Xiong received his M.D. from Anhui Medical University in 1984 and M.Sc. from Sun Yet-Sen University of Medical Science in 1987. He received his Ph.D. from the Department of Pharmacology at the University of Ottawa in 1995 and had his postdoctoral training in the Department of Physiology at the University of Toronto from 1995 to 1999. He is a recognized expert on the function of ion channels and membrane receptors in ischemic brain injury. Dr. Xiong has been awarded $4 million in grants from the NIH/NINDs to fund ion channel research.

He received Ph.D from University of California. Currently he is working as associate Dean for Research Department of Biomedical Science at Florida Atlantic University.

Structure and Function of Neurotransmitter Enzymes and Receptors; Mechanism of Signal Transduction and Neuronal Degeneration; Neurotransmission and Neurological Disorders.

Dr. Byron D. Ford is a Professor in the Department of Neurobiology and the Director of the Neuroprotection, Neurorepair and Stroke Program at the Morehouse School of Medicine in Atlanta, GA. Dr. Ford is an expert in the cellular and molecular events associated with stroke and acute brain injuries. In 2005 he published a groundbreaking research article showing that neureglin-1 can protect neurons and reduce inflammation in an animal model of stroke. Dr. Ford received his Ph.D. from Meharry Medical College and completed postdoctoral studies at Harvard Medical School and the NIH. Dr. Ford has received numerous honors and recent recognition by the Southeast BIO Investor.

Dr. Robin Sellar is Head of the Neuroradiology Department. He has built up the Interventional Neuroradiology department over the past 15 years. He is editor in chief of Neurointerventionalist, an editor of Neuroradiology and also of Patient Centred Care. Dr Sellar holds degrees in Psychology as well as Medicine and uniquely in this country he is not only a Fellow of the Royal College of Radiologists but also the Colleges of Physicians and Surgeons. He has written extensively on neurovascular intervention with over 75 publications in the last 5 years including many contributions to books. He has been awarded 8 prizes and scholarships for his academic work.

Dr. Bayley is currently the Medical Director of the Brain and Spinal Cord rehabilitation Program at the UHN- Toronto Rehabilitation Institute. He is currently an Associate Professor at University of Toronto. He is appointed as a Clinician Scientist at Toronto Rehab and associate scientist at the Institute for Clinical and Evaluative Sciences (ICES) and the Heart and Stroke Foundation Centre for Stroke Recovery. He has a strong interest in the field of knowledge translation i.e. how the best evidence can be implemented into practice and how to measure its uptake by clinicians. He is one of the Principle investigators on the Canadian Stroke Network SCORE project (Stroke Canada Optimization of Rehabilitation by Evidence). He is co-chair of the Best Practices committee and author of the Best Practice Guidelines for the Canadian Stroke strategy. He also chairs the Stroke Evaluation Advisory Committee of the Ontario Stroke Network. He has 65 publications in his areas of research and has co-authored web-based guidelines, application and systematic reviews.

Dr Schmidt is a member of the European Force on Age-related White Matter Changes. He is also a member of the Austrian Society of Neuroimaging, and the Austrian Society for Stroke Research, and the president of the Austrian Alzheimer Society, and of the Working Group Neuroepidemiology and Prevention of the Austrian Neurological Society. He is a member of the VITATOPS-Steering Committee: a worldwide project on homocysteine-lowering multivitamin therapy in patients with recent ischaemic attacks or stroke. Dr Schmidt is or has been a principle investigator in the CASCADE study on diabetes and cortical atrophy stratified by abscence and presence of hypertension, in the Honolulu-Asia Aging Study, and in the Austrian Stroke Prevention Study.

Dr Schmidt`s clinical and research interests focus on the managing and treatment of vascular dementia combined with cerebrovascular diseases, in the pathophysiology of vascular cognitive impairment and Alzheimer`s Disease, in white matter lesion progression in patients with small vessel diseases, and in the prevention of diabetes.

Dr. Andreas GRUBER is Medical School at University of Vienna, Austria, with graduation 1992; Board certified in Austria for Neurosurgery and Intensive Care Medicine;Associate Professor of Neurosurgery since 2001. He was Austrian representative to the European Association of Neurosurgical Societies [EANS] and ExCom member of the EANS cerebrovascular section. His Clinical work and research focused on microsurgical and endovascular management of cerebrovascular diseases and neurosurgical intensive care medicine.

Professor Jan More wood is physiotherapist since 1997 BSc in 2005 Master in Public Health in 2006. Dr. rer. medic . In 2007 , habilitation in 2010 professor in physiotherapy since 2008. He is head of the scientific institutions in Kreischa , Germany and so lecturer at the Department of Public Health , University of Dresden , Germany .

His main research interests are in neurological rehabilitation and motor workout after stroke and other neurological diseases . He works as a researcher in this field.

Dr Staykov’s recent research is related to the treatment of intraventricular hemorrhage, the development of imaging analysis techniques and quantification of perihemorrhagic brain edema, and therapeutic hypothermia in ischemic and hemorrhagic stroke. He is a member of the Executive Committee and Regional Coordinator for Middle and South-Eastern Europe for the EuroHYP-1 trial. Dr Staykov has published more than 50 peer-reviewed articles in international scientific journals and has co-authored guidelines of the Neurocritical Care Society and the European Stroke Organization.

Dr. Hen Hallevi is attending physician, department of Neurology, Soroka Medical Center, Beer-Sheva, Israel; Vascular Neurology fellow, University of Texas at Houston and he is attending physician, Neurology department and Stroke unit, Tel-Aviv Sourasky, MC, Tel-Aviv, Israel.

Dr. Yukito SHINOHARA graduated from Keio University School of Medicine, Tokyo, Japan. He became Professor and Chairman of Neurology, Tokai University School of Medicine on 1983 and worked as a clinical neurologist, and clinical researcher of stroke and cerebral hemodynamics. He is currently Member at Large of World Stroke Organization, Immediate Past President of the Japan Stroke Society and the Asia Pacific Stroke Organization, and Chairman of the Japanese Stroke Guidelines in 2004 and 2009. His present　 position is a Director, Federation of National Public Service Personnel Mutual Aid Associations Tachikawa Hospital, Tokyo, and Professor Emeritus, Tokai University School of Medicine. He published 201 original papers and 8 reviews in English, and also wrote more than 256 original papers and 500 reviews and text books in Japanese

Stroke treatment

Dr. Paul Macaire OSSOU-NGUIET work actively for the development of neurovascular Congo. Main editor of the national plan of action against stroke in Congo, he set up the first stroke unit in Central Africa, and is the first to achieve thrombolysis in the acute phase of stroke in Central Africa. Author of several publications in African and international journals in the field of general neurology and in stroke. He was one of the investigator of CADISP study in the Lille team.

Stroke Treatment

Dr. Wang is Director of Neuroapoptosis Drug Discovery Laboratory, Department of Neurosurgery, Brigham and Women’s Hospital/Harvard Medical School. Dr. Wang received her PhD from Hebrew University of Jerusalem. She did her postdoctoral training at University of Michigan and Harvard Medical School. Dr. Wang has published about 70 peer-reviewed articles and has served as the Guest Editor, Handling Editor, and Editorial Board Member for a number of peer-reviewed journals, as well as the scientist reviewer for institutes or foundations including NIH, DOD, BSF, and others, and invited reviewer for 30 peer-reviewed journals.

The identification of candidate therapeutics and potential targets for therapeutic intervention in neurological disorders including adult stroke, newborn brain injury, Amyotrophic Lateral Sclerosis, and Huntington’s disease. Another main interest concerns the fundamental mechanisms of neurological diseases.

Dr. Andrew Grande originates from Minneapolis/St. Paul. He grew up in the Minneapolis lakes area and then later moved to St. Paul where he attended St. Thomas Academy for high school. He graduated from St. Olaf College (Northfield, MN) with a BA in chemistry and then attended the University of Minnesota Medical School. During college and medical school, he was very active in research activities at the University of Minnesota, working in the laboratories of Esam El. Fakahany, Virginia Seybold and Walter Low. These experiences later culminated in a burning curiosity and passion for the use of stem cells to treat stroke.

Dr. Vijay K Sharma is the current recipient of the prestigious Clinician Scientist Award from National Medical Research Council, Singapore. He has published 187 peer reviewed scientific papers and 19 book chapters. Dr. Sharma is Associate Editor for BMC Neurology and serves on the editorial boards of many scientific journals including Stroke, Journal of Stroke, Neural Regeneration Research, Recent Patents on Medical Imaging, Journal of Behavioral and Brain Science, World Journal of Hypertension, ISRN Neurology, American Journal of Cardiovascular Diseases, World Journal of Neurology, Journal of Neurology & Translational Neuroscience (JNTN), International Journal of Medical Sciences and Biotechnology, Advances in Neuroscience Research and Neurological Research and Therapy.

Thrombolysis in acute stroke, especially sonothrombolysis, Blood pressure management in acute ischemic stroke, Advanced applications of transcranial Doppler in cerebrovascular diseases, Intracranial stenosis, Assessment of cerebral hemodynamics with cerebrovascular ultrasonography.